Physicochemical properties, drug likeness, ADMET, DFT studies, and in vitro antioxidant activity of oxindole derivatives

dc.contributor.authorGoncagül Serdaroğlu
dc.date.accessioned2024-03-08T05:03:20Z
dc.date.available2024-03-08T05:03:20Z
dc.date.issued2023tr
dc.departmentEğitim Fakültesitr
dc.description.abstractPoor pharmacokinetic and safety profiles create significant hurdles in the drug development process. This work focuses on a detailed understanding of drug discovery interplay among physicochemical, pharmacokinetic, toxicity endpoints, and antioxidant properties of oxindole derivatives. DFT compıutations were also performed at B3LYP/6-311G** level to evaluate the physicochemical properties, global reactivity features, and intramolecular interactions. The BOILED-Egg pharmacokinetic model envisaged gastrointestinal absorption, blood-brain barrier penetration, and no interaction with p-glycoprotein for compounds C1 and C2. The physicochemical evaluation revealed that C1 possesses superior drug-like properties fit for oral absorption. Both derivatives were predicted to have high plasma protein binding, efficient distribution, and inhibiting CYP 450 major isoforms but serve as substrates only for a few of them. Both molecules have mild to moderate clearance rates. Out of ten toxicity parameters, only hepatotoxicity was predicted. DFT results implied that the meta position of the -OH group made the possibility of charge transfer greater than -para positioned -OH, due to the ΔNmax (eV) values of molecules C1 and C2 being calculated at 2.596 and 2.477, respectively. Both C1 and C2 exhibited a concentration dependant DPPH and ABTS radical scavenging activity. The chemical structure-physicochemical-pharmacokinetic relationship identified the meta position as the favorite for the electron-withdrawing hydroxyl group. This provides useful insight to medicinal chemists to design 6-chlorooxindole derivatives with an acceptable drug-like and pharmacokinetic property.tr
dc.identifier.doi10.1016/j.compbiolchem.2023.107861en_US
dc.identifier.endpage107861tr
dc.identifier.issue1tr
dc.identifier.pmid37060784en_US
dc.identifier.scopus2-s2.0-85152238515en_US
dc.identifier.scopusqualityN/A
dc.identifier.startpage107861tr
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S147692712300052X?via%3Dihub
dc.identifier.urihttps://hdl.handle.net/20.500.12418/14982
dc.identifier.volume104tr
dc.identifier.wosWOS:000983800000001en_US
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElseviertr
dc.relation.ispartofComputational Biology and Chemistryen_US
dc.relation.publicationcategoryUluslararası Hakemli Dergide Makale - Kurum Öğretim Elemanıtr
dc.rightsinfo:eu-repo/semantics/openAccesstr
dc.titlePhysicochemical properties, drug likeness, ADMET, DFT studies, and in vitro antioxidant activity of oxindole derivativesen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
A.4.pdf
Boyut:
96.63 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: